Baseline depression severity as moderator of depression outcomes between cognitive behavioral therapy vs pharmacotherapy: An individual patient data meta-analysis

JAMA Psychiatry

Volumn 72, Issue 11, 2015, Pages 1102-1109

  Weitz, Erica S ^a   Hollon, Steven D ^b   Twisk, Jos ^a   Van Straten, Annemieke ^a   Huibers, Marcus J H ^a   David, Daniel ^c   DeRubeis, Robert J ^d   Dimidjian, Sona ^e   Dunlop, Boadie W ^f   Cristea, Ioana A ^c   Faramarzi, Mahbobeh ^g   Hegerl, Ulrich ^h   Jarrett, Robin B ⁱ   Kheirkhah, Farzan ^j   Kennedy, Sidney H ^k   Mergl, Roland ^h   Miranda, Jeanne ^l   Mohr, David C ^m   Rush, A John ⁿ   Segal, Zindel V ^k   Siddique, Juned ^m   Simons, Anne D ^o   Vittengl, Jeffrey R ^p   Cuijpers, Pim ^a   more..

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

^b VANDERBILT UNIVERSITY   (United States)

^c BABE BOLYAI UNIVERSITY   (Romania)

^d UNIVERSITY OF PENNSYLVANIA   (United States)

^e UNIVERSITY OF COLORADO   (United States)

^f EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^g BABOL UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^h UNIVERSITY OF LEIPZIG   (Germany)

ⁱ UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^j BABOL UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^k UNIVERSITY OF TORONTO   (Canada)

^l UNIVERSITY OF CALIFORNIA   (United States)

^m NORTHWESTERN UNIVERSITY   (United States)

ⁿ NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^o UNIVERSITY OF NOTRE DAME   (United States)

^p TRUMAN STATE UNIVERSITY   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT;

ARTICLE; BECK DEPRESSION INVENTORY; COGNITIVE THERAPY; DEPRESSION; DISEASE SEVERITY; DRUG THERAPY; DSM-II; DSM-III; DSM-IV; EMBASE; HAMILTON DEPRESSION RATING SCALE; HUMAN; MEDICAL SOCIETY; META ANALYSIS; OUTCOME ASSESSMENT; PSYCHOPHARMACOTHERAPY; PSYCINFO; QUALITY CONTROL; RANDOMIZED CONTROLLED TRIAL (TOPIC); ADULT; DEPRESSIVE DISORDER; PROCEDURES; SEVERITY OF ILLNESS INDEX; STATISTICS AND NUMERICAL DATA;

ADULT; ANTIDEPRESSIVE AGENTS; COGNITIVE THERAPY; DEPRESSIVE DISORDER; HUMANS; PATIENT OUTCOME ASSESSMENT; RANDOMIZED CONTROLLED TRIALS AS TOPIC; SEVERITY OF ILLNESS INDEX;

EID: 84946562710     PISSN: 2168622X     EISSN: None     Source Type: Journal    
DOI: 10.1001/jamapsychiatry.2015.1516     Document Type: Article

References (48)

1. Mulrow CD, Williams JW Jr, Chiquette E, et al. Efficacy of newer medications for treating depression in primary care patients. Am J Med. 2000;108(1): 54-64.
2. Churchill R, Hunot V, Corney R, et al. A systematic review of controlled trials of the effectiveness and cost-effectiveness of brief psychological treatments for depression. Health Technol Assess. 2001;5(35): 1-173.
3. Butler AC, Chapman JE, Forman EM, Beck AT. The empirical status of cognitive-behavioral therapy: A review of meta-analyses. Clin Psychol Rev. 2006;26(1): 17-31.
4. Dobson KS. Ameta-analysis of the efficacy of cognitive therapy for depression. J Consult Clin Psychol. 1989;57(3): 414-419.
5. De Maat S, Dekker J, Schoevers R, De Jonghe F. Relative efficacy of psychotherapy and pharmacotherapy in the treatment of depression: Ameta-analysis. Psychother Res. 2006;16(5): 566-578.
6. Robinson LA, Berman JS, Neimeyer RA. Psychotherapy for the treatment of depression: A comprehensive review of controlled outcome research. Psychol Bull. 1990;108(1): 30-49.
7. Cuijpers P, van Straten A, van Oppen P, Andersson G. Are psychological and pharmacologic interventions equally effective in the treatment of adult depressive disorders? ameta-analysis of comparative studies. J Clin Psychiatry. 2008;69(11): 1675-1685.
8. Gelenberg AJ, Freeman MP, Markowitz JC, et al. Treatment of PatientsWith Major Depressive Disorder. 3rd ed.Washington, DC: American Psychiatric Association; 2010.
9. Anderson I, Ferrier I, Baldwin R, et al. Evidence-Based Guidelines for Treating Depressive DisordersWith Antidepressants: A Revision of the 2000 British Association for Psychopharmacology Guidelines. London, England: SAGE Publications Ltd; 2008: 343-396.
10. Elkin I, Gibbons RD, Shea MT, et al. Initial severity and differential treatment outcome in the National Institute of Mental Health Treatment of Depression Collaborative Research Program. J Consult Clin Psychol. 1995;63(5): 841-847.
11. Rush AJ, Beck AT, KovacsM, Hollon S. Comparative efficacy of cognitive therapy and pharmacotherapy in the treatment of depressed outpatients. Cognit Ther Res. 1977;1(1): 17-37.
12. Murphy GE, Simons AD,Wetzel RD, Lustman PJ. Cognitive therapy and pharmacotherapy: Singly and together in the treatment of depression. Arch Gen Psychiatry. 1984;41(1): 33-41.
13. Hollon SD, DeRubeis RJ, Evans MD, et al. Cognitive therapy and pharmacotherapy for depression: Singly and in combination. Arch Gen Psychiatry. 1992;49(10): 774-781.
14. DeRubeis RJ, Hollon SD, Amsterdam JD, et al. Cognitive therapy vs medications in the treatment of moderate to severe depression. Arch Gen Psychiatry. 2005;62(4): 409-416.
15. Siddique J, Chung JY, Brown CH, Miranda J. Comparative effectiveness of medication versus cognitive-behavioral therapy in a randomized controlled trial of low-income youngminority women with depression. J Consult Clin Psychol. 2012;80(6): 995-1006.
16. Driessen E, Cuijpers P, Hollon SD, Dekker JJM. Does pretreatment severity moderate the efficacy of psychological treatment of adult outpatient depression? ameta-analysis. J Consult Clin Psychol. 2010;78(5): 668-680.
17. Fournier JC, DeRubeis RJ, Hollon SD, et al. Antidepressant drug effects and depression severity: A patient-levelmeta-analysis. JAMA. 2010; 303(1): 47-53.
18. DeRubeis RJ, Gelfand LA, Tang TZ, Simons AD. Medications versus cognitive behavior therapy for severely depressed outpatients: Mega-analysis of four randomized comparisons. Am J Psychiatry. 1999;156(7): 1007-1013.
19. Riley RD, Lambert PC, Abo-Zaid G. Meta-analysis of individual participant data: Rationale, conduct, and reporting. BMJ. 2010;340: C221.
20. Cuijpers P, Berking M, Andersson G, Quigley L, Kleiboer A, Dobson KS. Ameta-analysis of cognitive-behavioural therapy for adult depression, alone and in comparison with other treatments. Can J Psychiatry. 2013;58(7): 376-385.
21. Higgins JP, Green S, eds. Chapter 8: Assessing risk of bias in included studies. In: Cochrane Handbook for Systematic Reviews of Interventions. Version 5.1.0. http://handbook.cochrane.org/. Updated March 2011. Accessed August 10, 2015.
22. Borenstein M, Hedges LV, Rothstein HR. Introduction to Meta-analysis. Sussex, England: Wiley Inc; 2009.
23. Hedges L, Olkin I. Statistical Methods for Meta-analysis. Orlando, FL: Academic Press; 1985.
24. Duval S, Tweedie R. Trim and fill: A simple funnel-plot-based method of testing and adjusting for publication bias in meta-analysis. Biometrics. 2000;56(2): 455-463.
25. Egger M, Davey Smith G, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ. 1997;315(7109): 629-634.
26. HamiltonM. A rating scale for depression. J Neurol Neurosurg Psychiatry. 1960;23: 56-62.
27. Beck AT,Ward CH, MendelsonM, Mock J, Erbaugh J. An inventory for measuring depression. Arch Gen Psychiatry. 1961;4: 561-571.
28. Beck AT, Steer RA, Brown GK. The Beck Depression Inventory. 2nd ed. San Antonio, TX: Psychological Corp; 1996.
29. Dunner DL, Schmaling KB, Hendrickson H, Becker J, Lehman A, Bea C. Cognitive therapy versus fluoxetine in the treatment of dysthymic disorder. Depression. 1996;4(1): 34-41.
30. Faramarzi M, Alipor A, Esmaelzadeh S, Kheirkhah F, Poladi K, Pash H. Treatment of depression and anxiety in infertile women: Cognitive behavioral therapy versus fluoxetine. J Affect Disord. 2008;108(1-2): 159-164.
31. Donders AR, van der Heijden GJ, Stijnen T, Moons KG. Review: A gentle introduction to imputation ofmissing values. J Clin Epidemiol. 2006;59(10): 1087-1091.
32. Bower P, Kontopantelis E, Sutton A, et al. Influence of initial severity of depression on effectiveness of low intensity interventions: Meta-analysis of individual patient data. BMJ. 2013; 346: F540.
33. Stewart LA, Parmar MK. Meta-analysis of the literature or of individual patient data: Is there a difference? Lancet. 1993;341(8842): 418-422.
34. Vickers AJ, Cronin AM, Maschino AC, et al; Acupuncture Trialists' Collaboration. Individual patient datameta-analysis of acupuncture for chronic pain: Protocol of the Acupuncture Trialists' Collaboration. Trials. 2010;11: 90.
35. Frank E, Prien RF, Jarrett RB, et al. Conceptualization and rationale for consensus definitions of terms in major depressive disorder: Remission, recovery, relapse, and recurrence. Arch Gen Psychiatry. 1991;48(9): 851-855.
36. National Institute for Clinical Excellence. The Treatment and Management of Depression in Adults. London, England: National Institute for Clinical Excellence; 2009.
37. Miranda J, Chung JY, Green BL, et al. Treating depression in predominantly low-income young minoritywomen: A randomized controlled trial. JAMA. 2003;290(1): 57-65.
38. Bagby RM, Ryder AG, Schuller DR, Marshall MB. The Hamilton Depression Rating Scale: Has the gold standard become a lead weight? Am J Psychiatry. 2004;161(12): 2163-2177.
39. Wisniewski SR, Rush AJ, Nierenberg AA, et al. Can phase III trial results of antidepressant medications be generalized to clinical practice? a STAR∗D report. Am J Psychiatry. 2009;166(5): 599-607.
40. Cuijpers P, Hollon SD, van Straten A, Bockting C, Berking M, Andersson G. Does cognitive behaviour therapy have an enduring effect that is superior to keeping patients on continuation pharmacotherapy? ameta-analysis. BMJ Open. 2013;3(4): E002542. doi: 10.1136/bmjopen-2012 -002542.
41. Blackburn IM, Bishop S, Glen AI, Whalley LJ, Christie JE. The efficacy of cognitive therapy in depression: A treatment trial using cognitive therapy and pharmacotherapy, each alone and in combination. Br J Psychiatry. 1981;139: 181-189.
42. Blackburn IM, Moore RG. Controlled acute and follow-up trial of cognitive therapy and pharmacotherapy in out-patients with recurrent depression. Br J Psychiatry. 1997;171: 328-334.
43. Hautzinger M, de Jong-Meyer R, Treiber R, Rudolf GA, Thien U.Wirksamkeit Kognitiever Verhaltenstherapie, Pharmakotherapie und deren Kombination bei nicht-endogenen, unipolaren Depressionen. Zeitschr Klin Psychol. 1996;25: 130-145.
44. Marshall MB, Zuroff DC, McBride C, Bagby RM. Self-criticism predicts differential response to treatment for major depression. J Clin Psychol. 2008;64(3): 231-244.
45. McKnight DL, Nelson-Gray RO, Barnhill J. Dexamethasone suppression test and response to cognitive therapy and antidepressant medication. Behav Ther. 1992;23: 99-111.
46. Scott AI, Freeman CP. Edinburgh primary care depression study: Treatment outcome, patient satisfaction, and cost after 16 weeks. BMJ. 1992; 304(6831): 883-887.
47. Shamsaei F, Rahimi A, Zarabian MK, Sedehi M. Efficacy of pharmacotherapy and cognitive therapy, alone and in combination in major depressive disorder. Hong Kong J Psychiatry. 2008;18: 76-80.
48. Thompson LW, Coon DW, Gallagher-Thompson D, Sommer BR, Koin D. Comparison of desipramine and cognitive/behavioral therapy in the treatment of elderly outpatients with mild-to-moderate depression. Am J Geriatr Psychiatry. 2001;9(3): 225-240.